This invention disclosed medical catheters with surface hydrophilic coatings. Said catheters were grafted with a thin layer of zwitterions, which forms lubricious water layer when contacted with human body liquids or other water solutions, to lower the surface friction and mechanical damage to human body. One benefit of the present invention is due to the excellent biocompatibility and tight bonding between modification material and catheter substrate, the modification will stably stay on the substrate during usage, to avoid the potential side effects caused by lubricants. This modification can be applied to multiple material surfaces, including but not limited to silicone rubber, polyurethane, rubber, polyetheretherketone, polyethylene, polypropylene, polyvinyl chloride, nylon, ABS (Acylonitrile Butadiene Styrene), and polycarbonate.

Methods are disclosed for the reduction or elimination of bacterial biofilms on biological and non-biological surfaces, as well as methods for the treatment of wounds, skin lesions, mucous membrane lesions, and other biological surfaces infected or contaminated with bacterial biofilms using compositions comprising thermolysin.

A flow blocking catheter including an inner tube, a flow blocking member and an outer tube is provided. The flow blocking member is self-expandable and sleeved on an exterior of the inner tube. At least a proximal end of the self-expandable flow blocking member is attached to an outer circumference of the inner tube. The outer tube is movably sleeved on the exterior of the inner tube to restrict an expansion of the flow blocking member. In this way, expansion of the flow blocking member is able to be controlled simply by pushing/retracting the outer or inner tube to offer a fast shifting between different configurations. The flow blocking member is able to occlude blood flow with a controllably expansion to lower stimulation to the wall of the blood vessel and avoid the easy bursting of the balloon.

A flow blocking catheter including an inner tube, an outer tube and a flow blocking member is provided. The flow blocking member has one end attached to an outer circumference of the inner tube and the other end attached to a distal end of the outer tube. The flow blocking member is configured to expand as the outer tube moves toward a distal end of the inner tube and to collapse as the outer tube moves away from the distal end of the inner tube. In this way, expansion of the flow blocking member is able to be controlled simply by pushing/retracting the outer or inner tube to offer a fast shifting between different configurations. The flow blocking member is able to occlude blood flow with a controllably expansion to lower stimulation to the wall of the blood vessel and avoid the easy bursting of the balloon.

A drug coating layer that prevents breakage of elongated drug crystals on a balloon surface while maintaining the drug crystals in an appropriate shape to act on the living body includes plural elongated bodies which are crystals of a water-insoluble drug each extending from the surface of the balloon at various lengths and angles, and a water-soluble additive layer provided in a space between an outer surface of an aggregate of the elongated bodies and the balloon surface to fill a space between the elongated bodies. The outer surface of the additive layer being located outside the aggregate, being uneven connecting a plurality of tip ends and side surfaces of the elongated bodies to each other. The tip ends of the elongated bodies slightly protrude from the additive layer, and the side surfaces and/or tip surfaces of the elongated body are exposed on the surface of the additive layer.

A drug coating layer that prevents breakage of elongated drug crystals on a balloon surface while maintaining the drug crystals in an appropriate shape to act on the living body includes plural elongated bodies which are crystals of a water-insoluble drug each extending from the surface of the balloon at various lengths and angles, and a water-soluble additive layer provided in a space between an outer surface of an aggregate of the elongated bodies and the balloon surface to fill a space between the elongated bodies. The outer surface of the additive layer being located outside the aggregate, being uneven connecting a plurality of tip ends and side surfaces of the elongated bodies to each other. The tip ends of the elongated bodies slightly protrude from the additive layer, and the side surfaces and/or tip surfaces of the elongated body are exposed on the surface of the additive layer.

Medical articles formed from a polyurethane-based resin including a modifying oligomer provide enhanced properties. A modifying oligomer incorporated into a backbone, as a side chain, or both of the polyurethane-based resin formed by a diisocyanate, a polyglycol, and a diol chain extender has at least one, preferably two, alcohol moieties (C—OH) and a functional moiety. Exemplary modifying oligomers are: a diol-containing perfluoropolyether incorporated into the backbone, a monofunctional polysiloxane (e.g., monodialcohol-terminated polydimethylsiloxane) incorporated as the side chain, and combinations thereof. Medical articles herein are self-lubricating and/or anti-fouling.

Embodiments include formulations and methods for topical administration of sugar alcohol to treat a skin condition such as acne. A formulation can include a moisturizer, an emollient, a sugar alcohol and zinc. The sugar alcohol can be erythritol. The erythritol can be administered with zinc chloride. The erythritol and zinc chloride can be formulated at a molar ratio of about 3:1. The methods can also include administration of a therapeutic amount of a second agent such as benzoyl peroxide or a retinoid. Embodiments also include antimicrobial coatings that contain erythritol and zinc to reduce, negate, and prevent the proliferation and propagation of accumulating biofilm. The formulation can be used to clean and/or provide an antimicrobial coating on a medical device such as a catheter.

Embodiments include formulations and methods for topical administration of sugar alcohol to treat a skin condition such as acne. A formulation can include a moisturizer, an emollient, a sugar alcohol and zinc. The sugar alcohol can be erythritol. The erythritol can be administered with zinc chloride. The erythritol and zinc chloride can be formulated at a molar ratio of about 3:1. The methods can also include administration of a therapeutic amount of a second agent such as benzoyl peroxide or a retinoid. Embodiments also include antimicrobial coatings that contain erythritol and zinc to reduce, negate, and prevent the proliferation and propagation of accumulating biofilm. The formulation can be used to clean and/or provide an antimicrobial coating on a medical device such as a catheter.

A shunt system used to treat excess cerebrospinal fluid (CSF) accumulation is described. In some embodiments, the system utilizes various mechanical, electrical, or electromechanical concepts designed to either clean a portion of the shunt system, or customize CSF drainage.